Log in to save to my catalogue

IDDF2021-ABS-0122 No association between proton-pump inhibitor use and adverse clinical outcomes of...

IDDF2021-ABS-0122 No association between proton-pump inhibitor use and adverse clinical outcomes of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2568458766

IDDF2021-ABS-0122 No association between proton-pump inhibitor use and adverse clinical outcomes of COVID-19: a territory-wide cohort study of 8,675 patients

About this item

Full title

IDDF2021-ABS-0122 No association between proton-pump inhibitor use and adverse clinical outcomes of COVID-19: a territory-wide cohort study of 8,675 patients

Publisher

London: BMJ Publishing Group LTD

Journal title

Gut, 2021-09, Vol.70 (Suppl 2), p.A9-A10

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

BackgroundEvidence regarding the use of proton-pump inhibitors (PPIs) in COVID-19 patients remains elusive. We examined the impact of PPI use on clinical outcomes of COVID-19 patients in a territory-wide cohort.MethodsWe performed a retrospective cohort study using data from an electronic healthcare database managed by the Hospital Authority, Hong...

Alternative Titles

Full title

IDDF2021-ABS-0122 No association between proton-pump inhibitor use and adverse clinical outcomes of COVID-19: a territory-wide cohort study of 8,675 patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2568458766

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2568458766

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2021-IDDF.13

How to access this item